The American College of Rheumatology has issued a press release announcing The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices recommending rheumatology patients on some immunosuppressive medications qualify for a third dose of the COVID-19 vaccine.

Click the button below to read the press release which details this new development as well as best practices for staying safe during the continuing pandemic.